Ornithine transcarbamylase (OTC) deficiency is an X-linked inborn error of metabolism caused by mutations in the gene encoding ornithine carbamoyltransferase, which is a nuclear-encoded mitochondrial matrix enzyme that catalyzes the second step of the urea cycle in mammals. The gene discussed is OTC; the disease is hyperinsulinemic hypoglycemia, familial, 4.